These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 8455744)

  • 1. [Greater decrease in lung function in COPD during continuous rather than during symptom-oriented bronchodilator medication].
    Geijer R
    Ned Tijdschr Geneeskd; 1993 Mar; 137(10):517. PubMed ID: 8455744
    [No Abstract]   [Full Text] [Related]  

  • 2. [Greater deterioration of lung function in COPD during continuous than during symptom-oriented bronchodilator treatment].
    Maesen BL; Maesen FP
    Ned Tijdschr Geneeskd; 1993 Jun; 137(23):1158-60. PubMed ID: 8316313
    [No Abstract]   [Full Text] [Related]  

  • 3. FVC response in bronchoreversibility test.
    Chhabra SK
    Indian J Chest Dis Allied Sci; 2001; 43(1):9-11. PubMed ID: 11370510
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of stable chronic obstructive lung disease with inhaled corticosteroid].
    Vestbo J; Lange P
    Ugeskr Laeger; 2000 Jan; 162(4):520-3. PubMed ID: 10697457
    [No Abstract]   [Full Text] [Related]  

  • 5. [From COPD, COAD, CURS, CUSLK, CAO to CHAOS].
    Nolte D
    Med Klin (Munich); 1995 Jan; 90(1):1-2. PubMed ID: 7885298
    [No Abstract]   [Full Text] [Related]  

  • 6. Bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airway disease.
    Hahn DL
    N Engl J Med; 1993 Apr; 328(14):1044; author reply 1044-5. PubMed ID: 8450868
    [No Abstract]   [Full Text] [Related]  

  • 7. [Eight parameters of ventilatory function in evaluating the therapeutic effects of bronchodilators].
    Huang ZB
    Zhonghua Yi Xue Za Zhi; 1984 Jan; 64(1):29-32. PubMed ID: 6430490
    [No Abstract]   [Full Text] [Related]  

  • 8. Predicting response to bronchodilator therapy in chronic obstructive pulmonary disease.
    Pratter MR; Irwin RS
    Arch Intern Med; 1988 Sep; 148(9):1909-10. PubMed ID: 3415402
    [No Abstract]   [Full Text] [Related]  

  • 9. Response to inhaled bronchodilators in COPD.
    Anthonisen NR; Wright EC
    Chest; 1987 May; 91(5 Suppl):36S-39S. PubMed ID: 2882959
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhaled therapy in COPD: what are the benefits?
    Postma DS
    Respir Med; 1991 Nov; 85(6):447-9. PubMed ID: 1775669
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of domiciliary nebulizers in managing patients with severe COPD.
    Eiser N; Angus K; McHale S
    Respir Med; 2001 Apr; 95(4):265-74. PubMed ID: 11316108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Importance of spasm and way of reactivity to bronchodilatator of patients with chronic obstructive pulmonary disease (author's transl)].
    Sprung J
    Plucne Bolesti Tuberk; 1981; 33(1):8-13. PubMed ID: 7244024
    [No Abstract]   [Full Text] [Related]  

  • 13. Does the mode of inhalation affect the bronchodilator response in patients with severe COPD?
    Eiser NM; Phillips C; Wooler PA
    Respir Med; 2001 Jun; 95(6):476-83. PubMed ID: 11421505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recommendations of the German Respiratory League for treatment of patients with chronic obstructive bronchitis and pulmonary emphysema].
    Wettengel R; Böhning W; Cegla U; Criée C; Fichter J; Geisler L; Fabel H; Köhler D; Konietzko N; Lindemann H
    Med Klin (Munich); 1995 Jan; 90(1):3-7. PubMed ID: 7885301
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pharmacologic modification of effort dyspnea in children with CARA].
    Neijens HJ; Wesselius TR; Kerrebijn KF
    Ned Tijdschr Geneeskd; 1981 Aug; 125(32):1277-81. PubMed ID: 6791036
    [No Abstract]   [Full Text] [Related]  

  • 16. [Glucocorticoids treatment of exacerbation of chronic obstructive lung diseases].
    Dalsgarth OJ; Vestbo J; Lange P
    Ugeskr Laeger; 2000 Jan; 162(4):529-32. PubMed ID: 10697460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three phenotypes of obstructive lung disease in the elderly.
    Jo KW; Ra SW; Chae EJ; Seo JB; Kim NK; Lee JH; Kim EK; Lee YK; Kim TH; Huh JW; Kim WJ; Lee JH; Lee SM; Lim SY; Shin TR; Yoon HI; Sheen SS; Lee JS; Lee SD; Oh YM
    Int J Tuberc Lung Dis; 2010 Nov; 14(11):1481-8. PubMed ID: 20937191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Long-term effect of inhaled budesonide in patients with mild to moderate chronic obstructive lung disease. The Osterbro Study].
    Vestbo J; Sørensen T; Lange P; Brix A; Torre P; Viskum K
    Ugeskr Laeger; 2000 Jan; 162(4):493-7. PubMed ID: 10697447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary-function testing in the evaluation of bronchodilator agents.
    Menendez R; Kelly HW
    Clin Pharm; 1983; 2(2):120-8. PubMed ID: 6349904
    [No Abstract]   [Full Text] [Related]  

  • 20. Airflow limitation--reversible or irreversible.
    Lancet; 1988 Jan 2-9; 1(8575-6):26-7. PubMed ID: 2891892
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.